Stephanie Cape
Executive Director, Precision Medicine LabCorp
Seminars
Thursday 8th October 2026
Panel Discussion: Fit-for-Purpose CDx Strategies: Matching Testing Approaches to Development & Patient Access Needs
2:00 pm
- The CDx market is growing rapidly as precision medicine gains momentum and more targeted therapies enter clinical development
- While many pioneering biomarker programs begin in centralized laboratories, the long-term commercial vision often requires models to evolve to allow greater scalability and geographic accessibility
- This discussion will explore how sponsors are balancing scientific complexity, operational realities, and commercial goals as they navigate the transition from centralized testing toward decentralized and distributable CDx approaches
